Breast Cancer Treatment Market - Forecasts from 2019 to 2024

May 2019 | 116 pages | ID: B5C38324F644EN
Knowledge Sourcing Intelligence LLP

Abstracts

The breast cancer treatment market is projected to grow at a CAGR of 3.01% to reach US$15.82 billion by 2024. The breast cancer treatment market is expected to grow at a moderate pace during the forecast period due to the worldwide prevalence of breast cancer. The main reasons for the disease include the consumption of alcohol and greater birth weight. The growing adoption of unhealthy lifestyle conditions among women of different age groups is leading to higher incidences of cancer during the forecast period. Breast cancer survival rates vary greatly worldwide, ranging from 80% or more in the North American region, Sweden and Japan to around 60% in the middle-income countries and below 40% in low-income countries (Source: WHO). Growing awareness regarding self-care and self-management, technological advancements and R&D expenditure are further driving the market growth during the forecast period. Currently, available treatment includes medications, therapy devices, and technologies in addition to palliative or supportive care. However, the high cost of treatment may restrain the market growth during the forecast period.

Major industry players profiled as part of the report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., and IceCure Medical, Inc.

Segmentation

The breast cancer treatment market has been analyzed through the following segments:

• By Type of Breast Cancer
• Invasive
• Non-Invasive (in situ)
• By Diagnosis
• Blood Tests
• Mammogram
• Breast MRI
• Breast Ultrasound
• Breast Biopsy
• Others
• By Treatment
• Breast Cancer Surgery
• Radiation Therapy
• Chemotherapy
• ‘Hormone Therapy
• Targeted Therapy
• Supportive/ Palliative Care
• By Geography
• North America
• USA
• Canada
• Mexico
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

Contents

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Prevalence
  4.5.1. By age group
  4.5.2. By region
4.6. Product Pipeline
4.7. Innovations

5. BREAST CANCER TREATMENT MARKET BY TYPE OF BREAST CANCER

5.1. Invasive
5.2. Non-Invasive (in situ)

6. BREAST CANCER TREATMENT MARKET BY DIAGNOSIS

6.1. Blood Tests
6.2. Mammogram
6.3. Breast MRI
6.4. Breast Ultrasound
6.5. Breast Biopsy
6.6. Others

7. BREAST CANCER TREATMENT MARKET BY TREATMENT

7.1. Breast Cancer Surgery
7.2. Radiation Therapy
7.3. Chemotherapy
7.4. Hormone Therapy
7.5. Targeted Therapy
7.6. Supportive/ Palliative Care

8. BREAST CANCER TREATMENT MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentia
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. United Kingdom
  8.3.4. Spain
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. Israel
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. Japan
  8.5.3. South Korea
  8.5.4. India
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. Novartis AG
10.2. F. Hoffmann-La Roche Ltd
10.3. Bristol-Myers Squibb 10.3.1. Overview
10.4. AbbVie Inc.
10.5. AstraZeneca
10.6. Orbital Therapy
10.7. Cianna Medical, Inc.
10.8. IntraOp Medical Corporation
10.9. iCAD, Inc.
10.10. IceCure Medical, Inc.
LIST OF FIGURES
LIST OF TABLES